You ignore the reality that shorting can and is, often part of an accumulation strategy.
When people gloat about how the shorters must be hurting, it must make them laugh. Because they're accumulating on the cheap!
Look who's doing that!
As for don't engage, obviously there are holders who only come into HC infrequently. It's poorly researched, weaker holders who are the low hanging fruit.
As for the bone-headed number crunches, that was my line AND it was well thought out. I'd appreciate it if you realised just how much effort I went to make my point clearly on this. Because Teva took over Cephalon, and there were sound scientists who remained at Teva and were part of actively getting a new protocol up in the FDA for stem cell tests.
If you cared to trawl back over years of posts, I actually predicted that the FDA would do this. For this I was sneered at.
It's perfectly reasonable to make the point that Teva was a company which made a series of short sighted decisions. Oversimplifications are dangerous, but I made the point about bone-headedness to illustrate an important principle. And nobody managed to counter this in a serious way. Teva paid far too much for other acquisitions for drug trials which failed and then had to divest themselves of anything that resembled a clinical trial. No matter how fundamentally different MSB clinical trials are from drug trials (the latter is high risk).
How about a bit less in the way of instructions about how others should post? Your contributions are valuable, and others might post to complement them, and offer other perspectives.
Just remember: traders love weak holders and people who act on emotion. They love to trigger an emotional decision.
All IMO.
Even if you think mine or other posters are repetitious, it's not for YOU personally. It's for people who infrequently come here and could get shaken out. Putting people on ignore is not a solution in that context. Think about it please. Thanks.
MSB Price at posting:
$1.65 Sentiment: Buy Disclosure: Held
(20min delay)